Testing a library of 96 antineoplastic and cardiotherapeutic drugs routinely used in clinics, we found that doxorubicin was the strongest inducer of YAP/TAZ nuclear translocation in both breast cancer cells and hiPSC‐CMs. The gene discussed is WWTR1; the disease is breast carcinoma.